Search
for
Sort by
Research 91–120 of 333
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
- Frontal fibrosing alopecia treatment options
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- The risk of dementia with the use of 5 alpha reductase inhibitors
- Hormonal manipulation of benign prostatic hyperplasia
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Frontal fibrosing alopecia: efficacy of treatment modalities
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Algorithmic approach to the treatment of frontal fibrosing alopecia: A systematic review
- Common urologic diseases in older men and their treatment: how they impact fertility
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Finasteride versus dutasteride: a real-world economic evaluation.
- MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED?
- Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors – dutasteride and finasteride – in the presence of testosterone
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- 5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Treatment of Alopecia with New Approaches: An Updated Review